The platelet ATP and ADP receptors

C. Oury, E. Tóth-Zsámboki, J. Vermylen, Marc F. Hoylaerts

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Adenine nucleotides, ADP and ATP, are coreleased from dense granules during platelet activation, as well as from endothelial cells and damaged red blood cells following vascular injury. Through autocrine and paracrine mechanisms, these extracellular signaling molecules interact with the platelet P2 receptors to amplify ongoing platelet activation. Two receptors for ADP, the Gq-protein-coupled P2Y1 and Gi-protein-coupled P2Y12 and one receptor for ATP, the P2X1 ion channel, have been identified on platelets. Due to distinct pharmacological properties and differential regulation, the P2Y and P2X receptors essentially operate on different scales of time and distance and trigger selective intracellular signaling cascades. Recent advances in the understanding of the P2Y receptor physiology have reinforced the concept of these receptors as useful targets for antithrombotic therapy. The function of P2X1 in platelet activation only recently started to be unraveled. This review focuses on recent findings on the physiology of these platelet ADP and ATP receptors, their distinct downstream intracellular signaling pathways as well as on the available agonists, antagonists and inhibitors that allow their pharmacological discrimination.

Original languageEnglish
Pages (from-to)859-875
Number of pages17
JournalCurrent Pharmaceutical Design
Volume12
Issue number7
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Purinergic P2 Receptors
Platelet Activation
Blood Platelets
Purinergic P2X1 Receptors
Gq-G11 GTP-Binding Protein alpha Subunits
Pharmacology
Adenine Nucleotides
Vascular System Injuries
Ion Channels
Adenosine Diphosphate
Endothelial Cells
Adenosine Triphosphate
Erythrocytes
Proteins

Keywords

  • Adenine nucleotides
  • Antithrombotic therapy
  • Hemostasis
  • P2X
  • P2Y
  • P2Y
  • Thrombosis

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The platelet ATP and ADP receptors. / Oury, C.; Tóth-Zsámboki, E.; Vermylen, J.; Hoylaerts, Marc F.

In: Current Pharmaceutical Design, Vol. 12, No. 7, 03.2006, p. 859-875.

Research output: Contribution to journalArticle

Oury, C. ; Tóth-Zsámboki, E. ; Vermylen, J. ; Hoylaerts, Marc F. / The platelet ATP and ADP receptors. In: Current Pharmaceutical Design. 2006 ; Vol. 12, No. 7. pp. 859-875.
@article{131fa409f09a42a1863765b067bf5257,
title = "The platelet ATP and ADP receptors",
abstract = "Adenine nucleotides, ADP and ATP, are coreleased from dense granules during platelet activation, as well as from endothelial cells and damaged red blood cells following vascular injury. Through autocrine and paracrine mechanisms, these extracellular signaling molecules interact with the platelet P2 receptors to amplify ongoing platelet activation. Two receptors for ADP, the Gq-protein-coupled P2Y1 and Gi-protein-coupled P2Y12 and one receptor for ATP, the P2X1 ion channel, have been identified on platelets. Due to distinct pharmacological properties and differential regulation, the P2Y and P2X receptors essentially operate on different scales of time and distance and trigger selective intracellular signaling cascades. Recent advances in the understanding of the P2Y receptor physiology have reinforced the concept of these receptors as useful targets for antithrombotic therapy. The function of P2X1 in platelet activation only recently started to be unraveled. This review focuses on recent findings on the physiology of these platelet ADP and ATP receptors, their distinct downstream intracellular signaling pathways as well as on the available agonists, antagonists and inhibitors that allow their pharmacological discrimination.",
keywords = "Adenine nucleotides, Antithrombotic therapy, Hemostasis, P2X, P2Y, P2Y, Thrombosis",
author = "C. Oury and E. T{\'o}th-Zs{\'a}mboki and J. Vermylen and Hoylaerts, {Marc F.}",
year = "2006",
month = "3",
doi = "10.2174/138161206776056029",
language = "English",
volume = "12",
pages = "859--875",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - The platelet ATP and ADP receptors

AU - Oury, C.

AU - Tóth-Zsámboki, E.

AU - Vermylen, J.

AU - Hoylaerts, Marc F.

PY - 2006/3

Y1 - 2006/3

N2 - Adenine nucleotides, ADP and ATP, are coreleased from dense granules during platelet activation, as well as from endothelial cells and damaged red blood cells following vascular injury. Through autocrine and paracrine mechanisms, these extracellular signaling molecules interact with the platelet P2 receptors to amplify ongoing platelet activation. Two receptors for ADP, the Gq-protein-coupled P2Y1 and Gi-protein-coupled P2Y12 and one receptor for ATP, the P2X1 ion channel, have been identified on platelets. Due to distinct pharmacological properties and differential regulation, the P2Y and P2X receptors essentially operate on different scales of time and distance and trigger selective intracellular signaling cascades. Recent advances in the understanding of the P2Y receptor physiology have reinforced the concept of these receptors as useful targets for antithrombotic therapy. The function of P2X1 in platelet activation only recently started to be unraveled. This review focuses on recent findings on the physiology of these platelet ADP and ATP receptors, their distinct downstream intracellular signaling pathways as well as on the available agonists, antagonists and inhibitors that allow their pharmacological discrimination.

AB - Adenine nucleotides, ADP and ATP, are coreleased from dense granules during platelet activation, as well as from endothelial cells and damaged red blood cells following vascular injury. Through autocrine and paracrine mechanisms, these extracellular signaling molecules interact with the platelet P2 receptors to amplify ongoing platelet activation. Two receptors for ADP, the Gq-protein-coupled P2Y1 and Gi-protein-coupled P2Y12 and one receptor for ATP, the P2X1 ion channel, have been identified on platelets. Due to distinct pharmacological properties and differential regulation, the P2Y and P2X receptors essentially operate on different scales of time and distance and trigger selective intracellular signaling cascades. Recent advances in the understanding of the P2Y receptor physiology have reinforced the concept of these receptors as useful targets for antithrombotic therapy. The function of P2X1 in platelet activation only recently started to be unraveled. This review focuses on recent findings on the physiology of these platelet ADP and ATP receptors, their distinct downstream intracellular signaling pathways as well as on the available agonists, antagonists and inhibitors that allow their pharmacological discrimination.

KW - Adenine nucleotides

KW - Antithrombotic therapy

KW - Hemostasis

KW - P2X

KW - P2Y

KW - P2Y

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33645281204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645281204&partnerID=8YFLogxK

U2 - 10.2174/138161206776056029

DO - 10.2174/138161206776056029

M3 - Article

C2 - 16515502

AN - SCOPUS:33645281204

VL - 12

SP - 859

EP - 875

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 7

ER -